Chronic hyperglycaemia causes abnormal activation of PKC by upregulating the conversion of glyceraldehyde-3-phosphate (GAP) to dihydroxyacetone phosphate (DHAP) and diacylglycerol (DAG), which results in sustained activation of PKC. Here, PRRT2 is linked to Hyperglycemia.